Clinical features of epilepsy at 2 referral hospitals in Northern Iran

References

1. ↵
   1. Hauser WA,
   2. Kurland LT

   (1975) The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 16, 1–66.
2. ↵
   1. Simon RP,
   2. Greenberg DA,
   3. Aminoff MJ

   , eds (2009) Clinical Neurology (McGraw-Hill, New York (NY)), 7th ed.
3. ↵
   1. Forsgren L,
   2. Beghi E,
   3. Oun A,
   4. Sillanpää M

   (2005) The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 12, 245–253.
4. ↵
   1. Theodore WH,
   2. Spencer SS,
   3. Wiebe S,
   4. Langfitt JT,
   5. Ali A,
   6. Shafer PO,
   7. et al.

   (2006) Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia 47, 1700–1722.
5. ↵
   1. World Health Organization. Epilepsy

   (2012) (WHO, Geneva (CH)) Available from:http://www.who.int/mediacentre/factsheets/fs999/en/. Accessed October 2013; Updated October 2012.
6. ↵
   1. Engel P,
   2. Pedley T

   1. Bharucha NE,
   2. Carpio A,
   3. Gallo Diop A

   (2008) Epidemiology of epilepsy in developing countries. in Epilepsy: A Comprehensive Textbook, eds Engel P, Pedley T (Lippincott Williams & Wilkins, Philadelphia (PA)), 2nd ed, 89–101.
7. ↵
   1. Fisher RS,
   2. Acevedo C,
   3. Arzimanoglou A,
   4. Bogacz A,
   5. Cross JH,
   6. Elger CE,
   7. et al.

   (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55, 475–482.
8. ↵
   1. World Medical Association

   (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191–2194.
9. ↵
   1. Ebrahimi H,
   2. Shafa M,
   3. Hakimzadeh Asl S

   (2012) Prevalence of active epilepsy in Kerman, Iran: a house based survey. Acta Neurol Taiwan 21, 115–124.
10. 1. Inaloo S,
    2. Katibeh P

    (2011) An epidemiologic study of 389 children with epilepsy in southern Iran. Iranian Journal of Child Neurology 5, 15–20.
11. ↵
    1. Riyasi HR,
    2. Hassan Zadeh Taheri MM,
    3. Sharif Zadeh GR,
    4. Hosein Zadeh Chahkandook F

    (2008) [An epidemiological HR study of epilepsy and some clinical aspects of hospitalized epileptic patients in Birjand Valli-e-Asr hospital (2004-2006)]. Journal of Birjand University of Medical Sciences 15, 62–68, Persian.
12. ↵
    1. Fong GC,
    2. Kwan P,
    3. Hui AC,
    4. Lui CH,
    5. Fong JK,
    6. Wong V

    (2008) An epidemiological study of epilepsy in Hong Kong SAR, China. Seizure 17, 457–464.
13. ↵
    1. Burton KJ,
    2. Rogathe J,
    3. Whittaker R,
    4. Mankad K,
    5. Hunter E,
    6. Burton MJ,
    7. et al.

    (2012) Epilepsy in Tanzanian children: association with perinatal events and other risk factors. Epilepsia 53, 752–760.
14. ↵
    1. Wang WZ,
    2. Wu JZ,
    3. Wang DS,
    4. Dai XY,
    5. Yang B,
    6. Wang TP,
    7. et al.

    (2003) The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology 60, 1544–1545.
15. ↵
    1. Kobau R,
    2. Zahran H,
    3. Grant D,
    4. Thurman DJ,
    5. Price PH,
    6. Zack MM,
    7. et al.

    (2007) Prevalence of active epilepsy and health-related quality of life among adults with self-reported epilepsy in California: California Health Interview Survey, 2003. Epilepsia 48, 1904–1913.
16. ↵
    1. Noronha AL,
    2. Borges MA,
    3. Marques LH,
    4. Zanetta DM,
    5. Fernandes PT,
    6. de Boer H,
    7. et al.

    (2007) Prevalence and pattern of epilepsy treatment in different socioeconomic classes in Brazil. Epilepsia 48, 880–885.
17. ↵
    1. Wang W,
    2. Wu J,
    3. Dai X,
    4. Ma G,
    5. Yang B,
    6. Wang T,
    7. et al.

    (2008) Global campaign against epilepsy: assessment of a demonstration project in rural China. Bull World Health Organ 86, 964–969.
18. ↵
    1. Meyer AC,
    2. Dua T,
    3. Ma J,
    4. Saxena S,
    5. Birbeck G

    (2010) Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 88, 260–266.
19. ↵
    1. Clarke C,
    2. Howard R,
    3. Rossor M,
    4. Shorvon SD

    1. Shorvon S,
    2. Duncan J,
    3. Koepp M,
    4. Sander J,
    5. Smith S,
    6. Wal M

    (2009) Epilepsy and Related Disorders. in Neurology: A Queen Square Textbook, eds Clarke C, Howard R, Rossor M, Shorvon SD (Wiley-Blackwell, Oxford (UK)), 198–244.
20. ↵
    1. Picot MC,
    2. Baldy-Moulinier M,
    3. Daurès JP,
    4. Dujols P,
    5. Crespel A

    (2008) The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia 49, 1230–1238.
21. ↵
    1. Forsgren L

    (2005) Prevalence of epilepsy in adults in northern Sweden. Epilepsia 33, 450–458.
22. ↵
    1. Forsgren L,
    2. Beghi E,
    3. Oun A,
    4. Sillanpää M

    (2005) The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 12, 245–253.
23. ↵
    1. Faught E,
    2. Richman J,
    3. Martin R,
    4. Funkhouser E,
    5. Foushee R,
    6. Kratt P,
    7. et al.

    (2012) Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries. Neurology 78, 448–453.
24. ↵
    1. Beghi E,
    2. Hesdorffer D

    (2014) Prevalence of epilepsy--an unknown quantity. Epilepsia 55, 963–967.
25. ↵
    1. Bell GS,
    2. Neligan A,
    3. Sander JW

    (2014) An unknown quantity--the worldwide prevalence of epilepsy. Epilepsia 55, 958–962.